Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
$0.3590
-0.0050 ( -4.27% ) 43.5K
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
Market Data
Open
$0.3590
Previous close
$0.3640
Volume
43.5K
Market cap
$3.65M
Day range
$0.3300 - $0.3820
52 week range
$0.2208 - $2.2700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 80 | Aug 14, 2024 |
10-k/a | Quarterly Reports | 18 | May 31, 2024 |
10-q | Quarterly Reports | 79 | May 15, 2024 |
10-k | Annual reports | 106 | Apr 01, 2024 |
8-k | 8K-related | 14 | Mar 22, 2024 |
8-k | 8K-related | 13 | Jan 12, 2024 |